172 related articles for article (PubMed ID: 27665225)
1. The IMPACT-CABG trial: A multicenter, randomized clinical trial of CD133
Noiseux N; Mansour S; Weisel R; Stevens LM; Der Sarkissian S; Tsang K; Crean AM; Larose E; Li SH; Wintersperger B; Vu MQ; Prieto I; Li RK; Roy DC; Yau TM
J Thorac Cardiovasc Surg; 2016 Dec; 152(6):1582-1588.e2. PubMed ID: 27665225
[TBL] [Abstract][Full Text] [Related]
2. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
Stamm C; Kleine HD; Choi YH; Dunkelmann S; Lauffs JA; Lorenzen B; David A; Liebold A; Nienaber C; Zurakowski D; Freund M; Steinhoff G
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):717-25. PubMed ID: 17320570
[TBL] [Abstract][Full Text] [Related]
3. Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial.
Forcillo J; Stevens LM; Mansour S; Prieto I; Salem R; Baron C; Roy DC; Larose E; Masckauchan D; Noiseux N
Can J Cardiol; 2013 Apr; 29(4):441-7. PubMed ID: 23265095
[TBL] [Abstract][Full Text] [Related]
4. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
[TBL] [Abstract][Full Text] [Related]
5. Laser-supported CD133+ cell therapy in patients with ischemic cardiomyopathy: initial results from a prospective phase I multicenter trial.
Assmann A; Heke M; Kröpil P; Ptok L; Hafner D; Ohmann C; Martens A; Karluβ A; Emmert MY; Kutschka I; Sievers HH; Klein HM
PLoS One; 2014; 9(7):e101449. PubMed ID: 25000346
[TBL] [Abstract][Full Text] [Related]
6. Combined transepicardial and transseptal implantation of autologous CD 133+ bone marrow cells during bypass grafting improves cardiac function in patients with low ejection fraction.
Soetisna TW; Sukmawan R; Setianto B; Mansyur M; Murni TW; Listiyaningsih E; Santoso A
J Card Surg; 2020 Apr; 35(4):740-746. PubMed ID: 32048356
[TBL] [Abstract][Full Text] [Related]
7. Functional recovery of patients with ischemic cardiomyopathy treated with coronary artery bypass surgery and concomitant intramyocardial bone marrow mononuclear cell implantation--a long-term follow-up study.
Trifunović Z; Obradović S; Balint B; Ilić R; Vukić Z; Šišić M; Kostić J; Rusović S; Dobrić M; Ostojić G
Vojnosanit Pregl; 2015 Mar; 72(3):225-32. PubMed ID: 25958473
[TBL] [Abstract][Full Text] [Related]
8. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.
Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E
Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408
[TBL] [Abstract][Full Text] [Related]
9. Validating intramyocardial bone marrow stem cell therapy in combination with coronary artery bypass grafting, the PERFECT Phase III randomized multicenter trial: study protocol for a randomized controlled trial.
Donndorf P; Kaminski A; Tiedemann G; Kundt G; Steinhoff G
Trials; 2012 Jul; 13():99. PubMed ID: 22747980
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative CD133+ cell transplantation during coronary artery bypass grafting in ischemic cardiomyopathy.
Klein HM; Assmann A; Lichtenberg A; Heke M
Multimed Man Cardiothorac Surg; 2010 Jan; 2010(809):mmcts.2009.003947. PubMed ID: 24413679
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting in patients with ischemic cardiomyopathy.
Yoo KJ; Kim HO; Kwak YL; Kang SM; Jang YS; Lim SH; Hwang KC; Cho SW; Yang YS; Li RK; Kim BS
Can J Surg; 2008 Aug; 51(4):269-75. PubMed ID: 18815649
[TBL] [Abstract][Full Text] [Related]
12. [Autologous stem cell therapy with surgical myocardial revascularization - The Rostock University experience].
Yerebakan C; Uğurlucan M; Kaminski A; Westphal B; Liebold A; Steinhoff G
Anadolu Kardiyol Derg; 2009 Dec; 9(6):457-64. PubMed ID: 19965315
[TBL] [Abstract][Full Text] [Related]
13. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.
Bolli R; Chugh AR; D'Amario D; Loughran JH; Stoddard MF; Ikram S; Beache GM; Wagner SG; Leri A; Hosoda T; Sanada F; Elmore JB; Goichberg P; Cappetta D; Solankhi NK; Fahsah I; Rokosh DG; Slaughter MS; Kajstura J; Anversa P
Lancet; 2011 Nov; 378(9806):1847-57. PubMed ID: 22088800
[TBL] [Abstract][Full Text] [Related]
14. Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting.
Can A; Ulus AT; Cinar O; Topal Celikkan F; Simsek E; Akyol M; Canpolat U; Erturk M; Kara F; Ilhan O
Stem Cell Rev Rep; 2015 Oct; 11(5):752-60. PubMed ID: 26123356
[TBL] [Abstract][Full Text] [Related]
15. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.
Karantalis V; DiFede DL; Gerstenblith G; Pham S; Symes J; Zambrano JP; Fishman J; Pattany P; McNiece I; Conte J; Schulman S; Wu K; Shah A; Breton E; Davis-Sproul J; Schwarz R; Feigenbaum G; Mushtaq M; Suncion VY; Lardo AC; Borrello I; Mendizabal A; Karas TZ; Byrnes J; Lowery M; Heldman AW; Hare JM
Circ Res; 2014 Apr; 114(8):1302-10. PubMed ID: 24565698
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcome of Intra-Myocardial Injection of Autologous Bone Marrow Mononuclear Cells Combined with Isolated Coronary Artery Bypass Grafting for Patients with Chronic Ischemic Heart Failure.
Wang R; Zhang L; Wang Y; Gong Z; Xiao C; Wu Y; Ren C; Cheng N; Gao C
Heart Surg Forum; 2016 Jun; 19(3):E131-8. PubMed ID: 27355149
[TBL] [Abstract][Full Text] [Related]
17. Effect of Intramyocardial Grafting Collagen Scaffold With Mesenchymal Stromal Cells in Patients With Chronic Ischemic Heart Disease: A Randomized Clinical Trial.
He X; Wang Q; Zhao Y; Zhang H; Wang B; Pan J; Li J; Yu H; Wang L; Dai J; Wang D
JAMA Netw Open; 2020 Sep; 3(9):e2016236. PubMed ID: 32910197
[TBL] [Abstract][Full Text] [Related]
18. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.
Yerebakan C; Kaminski A; Westphal B; Donndorf P; Glass A; Liebold A; Stamm C; Steinhoff G
J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1530-9.e3. PubMed ID: 21664627
[TBL] [Abstract][Full Text] [Related]
19. Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction.
Ahmadi H; Baharvand H; Ashtiani SK; Soleimani M; Sadeghian H; Ardekani JM; Mehrjerdi NZ; Kouhkan A; Namiri M; Madani-Civi M; Fattahi F; Shahverdi A; Dizaji AV
Curr Neurovasc Res; 2007 Aug; 4(3):153-60. PubMed ID: 17691968
[TBL] [Abstract][Full Text] [Related]
20. Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis.
Donndorf P; Kundt G; Kaminski A; Yerebakan C; Liebold A; Steinhoff G; Glass A
J Thorac Cardiovasc Surg; 2011 Oct; 142(4):911-20. PubMed ID: 21376346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
